Woodcock's return to CDER may improve drug approval climate

05/19/2008 | RPM Report (free registration), The

Some analysts say Janet Woodcock's return to head the Center for Drug Evaluation & Research is having a positive impact on the drug approval environment at the FDA, citing more green lights for tough product approvals in recent months. Woodcock says there haven't been any changes to approval standards, but says that she has been involved in some recent approval decisions, particularly those using risk evaluation and mitigation strategies.

View Full Article in:

RPM Report (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA